Literature DB >> 2848569

The lipid composition of highly differentiated human hepatomas, with special reference to fatty acids.

I Eggens1, L Bäckman, A Jakobsson, C Valtersson.   

Abstract

The lipid compositions of homogenates and microsomal fractions derived from surgical samples of highly differentiated human hepatoma, morphologically normal regions outside the tumours and from normal livers were analysed. A few enzyme activities were also assayed. Hepatoma microsomes demonstrated considerably lowered levels of cytochromes P-450 and b5. Hepatoma homogenates exhibited increased levels of cholesterol, normal amounts of dolichyl-P and slightly lowered levels of total phospholipid. The levels of dolichol, dolichol ester and ubiquinone in hepatoma homogenates were prominently decreased. In tumour microsomes the levels of cholesterol and dolichyl phosphate were increased considerably while the levels of phospholipid and dolichol were lowered. The phospholipid composition of tumour homogenates was roughly similar to that of control tissue. In tumour microsomes the relative amounts of phosphatidylserine and phosphatidylinositol were about 30% decreased, whereas the major phospholipids showed minor increases in amount. The rate and pattern of incorporation of [3H]glycerol into individual phospholipids in liver slices from control and hepatoma tissue did not differ to any larger extent. The fatty acid composition of tumour homogenates exhibited minor differences in comparison to the control with the greatest changes in the sphingomyelin fraction. In hepatoma microsomes the fatty acid compositions of the major phospholipids were altered moderately, with evident decreases in the relative amounts of the long-chain polyunsaturated fatty acids. In hepatoma homogenates the fatty acid composition of dolichol esters differed only slightly from the control pattern. These results indicate that the major disturbance in the lipid metabolism of highly differentiated hepatomas is localized to the mevalonate pathway, thus affecting mainly the levels of cholesterol, dolichol and ubiquinone.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2848569      PMCID: PMC2013280     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  21 in total

1.  The phosphatides of some mouse ascites tumors and rat hepatomas.

Authors:  P H FIGARD; D M GREENBERG
Journal:  Cancer Res       Date:  1962-04       Impact factor: 12.701

2.  Coenzyme Q concerntration in proliferative lesions of liver.

Authors:  K A OSTERBERG; L W WATTENBERG
Journal:  Proc Soc Exp Biol Med       Date:  1961-11

Review 3.  The role of cholesterol in malignancy.

Authors:  H W Chen; A A Kandutsch; H J Heiniger
Journal:  Prog Exp Tumor Res       Date:  1978

4.  In vitro and in vivo synthesis of dolichol and other main mevalonate products in various organs of the rat.

Authors:  P G Elmberger; A Kalèn; E L Appelkvist; G Dallner
Journal:  Eur J Biochem       Date:  1987-10-01

5.  Sequential cycles of cholesterol and dolichol synthesis in mouse spleens during phenylhydrazine-induced erythropoiesis.

Authors:  J E Potter; M J James; A A Kandutsch
Journal:  J Biol Chem       Date:  1981-03-10       Impact factor: 5.157

Review 6.  Membrane fluidity in malignancy. Adversative and recuperative.

Authors:  M Shinitzky
Journal:  Biochim Biophys Acta       Date:  1984

7.  Isolation and characterization of endoplasmic reticulum and Golgi apparatus from hepatocyte nodules in male wistar rats.

Authors:  L C Eriksson; U B Torndal; G N Andersson
Journal:  Cancer Res       Date:  1983-07       Impact factor: 12.701

8.  Role of dolichyl phosphate in regulation of protein glycosylation in 2-acetylaminofluorene-induced carcinogenesis in rat liver.

Authors:  I Eggens; L C Eriksson; T Chojnacki; G Dallner
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

9.  Dolichol and dolichyl phosphate in human tissues.

Authors:  O Tollbom; G Dallner
Journal:  Br J Exp Pathol       Date:  1986-10

10.  Compartmentalization of phosphatidylethanolamine in microsomal membranes from rat liver.

Authors:  C Valtersson; G Dallner
Journal:  J Lipid Res       Date:  1982-08       Impact factor: 5.922

View more
  3 in total

1.  Inter-individual variability in levels of human microsomal protein and hepatocellularity per gram of liver.

Authors:  Z E Wilson; A Rostami-Hodjegan; J L Burn; A Tooley; J Boyle; S W Ellis; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  2003-10       Impact factor: 4.335

2.  Platelet-activating factor in cirrhotic liver and hepatocellular carcinoma.

Authors:  Muriel Mathonnet; Bernard Descottes; Denis Valleix; Véronique Truffinet; Francois Labrousse; Yves Denizot
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

3.  Differences in rates of incorporation of intravenously injected radiolabeled fatty acids into phospholipids of intracerebrally implanted tumor and brain in awake rats.

Authors:  T Nariai; J J DeGeorge; N H Greig; S Genka; S I Rapoport; A D Purdon
Journal:  Clin Exp Metastasis       Date:  1994-05       Impact factor: 5.150

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.